The European Commission on Friday launched a scheme to monitor exports of vaccines produced in EU plants and reject those it deems inappropriate -- amid a row with British-Swedish drugs giant AstraZeneca. "We paid these companies to increase production and now we expect them to deliver," EU Commission vice-president Valdis Dombrovskis told reporters. "Today's measure has been adopted with the utmost urgency. The aim is to provide us immediately with full transparency ... And if needed, it also will provide us with a tool to ensure vaccine deliveries." jug-dc/del/rl